Neurological complications of infliximab [7]

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 236-237

  Roos, Jonathan C P ^a   Ostor, Andrew J K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; NATALIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATION; DISEASE PREDISPOSITION; HUMAN; INFECTION RISK; JC VIRUS; LETTER; LYMPHOCYTOPENIA; NEUROLOGICAL COMPLICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; T LYMPHOCYTE; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS;

EID: 33846309675     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Jarand J, Zochodne DW, Martin LO, Voll C. Neurological complications of infliximab. J Rheumatol 2006;33:1018-20. Epub 2006 Mar 1.
2. Lima MA, Hanto DW, Curry MP, et al. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol 2005;11:46-50.
3. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-8.
4. Roos JC, Ostor AJ. Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection. Arthritis Rheum 2006;54:381-2.
5. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001;44:2862-9.
6. Imperato AK, Bingham III CO, Abramson SA. Overview of benefit/risk of biological agents. Clin Exp Rheumatol 2004;22 Suppl 35:S108-S114.
7. Genain CP, Islar J, Morgan K, et al. Natalizumab-induced immunosuppression in a case of progressive multifocal leukoencephalopathy (PML). Ann Neurol 2005;58 Suppl 9:S25.
8. Wachi K, Prasertsuntarasai T, Kishimoto M, Uramoto K. T-cell lymphopenia associated with infliximab and cyclophosphamide. Am J Med Sci 2005;330:48-51.
9. Yousry TA, Major EO, Ryshkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354:924-33.